Eli Lilly completes $3.2 billion acquisition of Morphic to enhance IBD treatments

Pallavi Madhiraju- August 18, 2024 0

Eli Lilly and Company has finalised its acquisition of Morphic Holding, Inc. in a landmark $3.2 billion deal, aimed at enhancing treatment options for inflammatory ... Read More

Eli Lilly and Company announces first Lilly Gateway Labs facility in San Diego for 2024

Pallavi Madhiraju- November 29, 2023 0

In a strategic move to strengthen its position in the life sciences sector, Eli Lilly and Company (NYSE: LLY) has revealed plans to inaugurate its ... Read More

Lilly to acquire gene therapy firm Akouos to discover hearing loss treatments

BNT Reporter- October 19, 2022 0

Lilly acquisition of Akouos : American pharmaceutical giant Eli Lilly and Company (Lilly) has agreed to acquire precision genetic medicine company Akouos in a cash ... Read More

Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

pallavi123- February 12, 2022 0

Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More

Lilly to launch pragmatic study of Covid-19 drug candidate bamlanivimab in New Mexico

pharmanewsdaily- December 19, 2020 0

Eli Lilly and Company (Lilly) has revealed plans to launch a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with Covid-19, in partnership with ... Read More

Bamlanivimab Covid-19 drug candidate : Lilly, UnitedHealth Group join forces for pragmatic study

pharmanewsdaily- December 6, 2020 0

Eli Lilly and Company (Lilly) has entered into a partnership with managed care company UnitedHealth Group to carry out a pragmatic study of bamlanivimab (LY-CoV555) ... Read More

Lilly’s Covid-19 candidate bamlanivimab gets FDA’s EUA

pharmanewsdaily- November 10, 2020 0

The US Food and Drug Administration (FDA) has issued emergency use authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg, the investigational neutralizing antibody of Eli Lilly ... Read More

Lilly, Amgen collaborate to boost supply of potential COVID-19 therapies

pharmanewsdaily- September 17, 2020 0

Eli Lilly and Company has entered into a global antibody manufacturing collaboration with Amgen to considerably boost the supply capacity for its potential COVID-19 therapies. ... Read More

Lilly begins phase 1 coronavirus antibody trial with LY-CoV555

pharmanewsdaily- June 1, 2020 0

Coronavirus antibody trial : US pharma giant Eli Lilly and Company (Lilly) said that patients have been dosed in a phase 1 clinical trial with ... Read More